Sandro Orru

Summary

Affiliation: University of Cagliari
Country: Italy

Publications

  1. pmc Mapping of the major psoriasis-susceptibility locus (PSORS1) in a 70-Kb interval around the corneodesmosin gene (CDSN)
    Sandro Orru
    Genetica Medica Dipartimento di Scienze Mediche, Universita degli Studi di Cagliari, Cagliari, Italy
    Am J Hum Genet 76:164-71. 2005
  2. ncbi request reprint Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients
    Giorgio La Nasa
    Cattedra di Ematologia, Centro Trapianti Midollo Osseo, Ospedale R Binaghi ASL 8, Dipartimento di Scienze Mediche Internistiche, Universita di Cagliari, Cagliari, Italy
    Biol Blood Marrow Transplant 13:1358-68. 2007

Collaborators

  • Roberto Littera
  • Giorgio La Nasa
  • Daniela Lisini
  • Sonia Nesci
  • Carlo Carcassi
  • Eugenia Piras
  • Claudio Giardini
  • Giovanni Caocci
  • Giada Giustolisi
  • Marina Mulargia
  • Franco Locatelli
  • Adriana Vacca
  • Arianna Ventrella
  • Nicola OrrĂ¹

Detail Information

Publications2

  1. pmc Mapping of the major psoriasis-susceptibility locus (PSORS1) in a 70-Kb interval around the corneodesmosin gene (CDSN)
    Sandro Orru
    Genetica Medica Dipartimento di Scienze Mediche, Universita degli Studi di Cagliari, Cagliari, Italy
    Am J Hum Genet 76:164-71. 2005
    ..Comparisons of the regions identical by descent among associated and nonassociated haplotypes highlighted a minimum region of 70 kb not recombinant with PSORS1, around the corneodesmosin (CDSN) gene...
  2. ncbi request reprint Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients
    Giorgio La Nasa
    Cattedra di Ematologia, Centro Trapianti Midollo Osseo, Ospedale R Binaghi ASL 8, Dipartimento di Scienze Mediche Internistiche, Universita di Cagliari, Cagliari, Italy
    Biol Blood Marrow Transplant 13:1358-68. 2007
    ..These data may be helpful in tailoring the intensity of GVHD prophylaxis and conditioning regimens in thalassemia patients receiving HSCT from an HLA-identical volunteer donor...